Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adult Solid Neoplasm × Topotecan × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 9 Neuroblastoma 8 Ovarian Neoplasms 6 Ganglioneuroblastoma 5 Uterine Cervical Neoplasms 3 Fallopian Tube Neoplasms 3 Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Recurrence 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Peritoneal Neoplasms 1 Pediatric Brain Tumor 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Fallopian Tube Mucinous Adenocarcinoma 1 Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1

Interventions

temsirolimus 1 ixabepilone 1 Sirolimus 1 Irinotecan 1 Erlotinib Hydrochloride 1 Epothilones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡